Related Experiment Video
Updated: Oct 25, 2025

13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
9.5K
Population screening for glaucoma in UK: current recommendations and future directions.
Sana Hamid1, Parul Desai1, Pirro Hysi2,3
1NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, UK.
Eye (London, England)
|August 4, 2021
Summary
Population screening for primary open-angle glaucoma (POAG) is not recommended due to insufficient evidence of accurate tests or improved outcomes. Future targeted screening may utilize polygenic risk prediction and AI analysis.
Area of Science:
- Ophthalmology
- Public Health
- Screening Programs
Background:
- Effective population screening for glaucoma is crucial for early diagnosis and preventing irreversible vision loss.
- The UK National Screening Committee (NSC) reviewed the viability of a population-based screening program for primary open-angle glaucoma (POAG).
Purpose of the Study:
- To summarize the UK NSC review on population-based screening for primary open-angle glaucoma (POAG).
- To discuss future directions for effective glaucoma screening strategies.
Main Methods:
- The UK NSC review examined six new studies published since 2015.
- Key questions addressed: accuracy of screening tests for POAG and improved outcomes compared to standard care.
Main Results:
- The review concluded that population screening for glaucoma is not currently recommended.
- There is insufficient evidence for a sufficiently accurate screening test or for better outcomes with screening compared to current care.
- Low disease prevalence leads to high false-positive rates, even with accurate tests.
Conclusions:
- Opportunistic case finding through General Ophthalmic Services is the primary method for glaucoma identification in the UK.
- Future effective screening may involve targeted approaches using polygenic risk prediction and deep learning for identifying high-prevalence subgroups.
- Increased public awareness of existing services is beneficial.
Related Concept Videos
Glaucoma: Overview
1000
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1000
Open Angle Glaucoma: Treatment
771
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
771
Angle Closure Glaucoma: Treatment
899
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
899

